Compare BIO-TECHNE Corp (TECH) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs State Street Technology Select Sector SPDR ETF — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while State Street Technology Select Sector SPDR ETF trades at $199.65 (market cap $132.74B). The key difference: State Street Technology Select Sector SPDR ETF is far larger — about 11.7× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while State Street Technology Select Sector SPDR ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and State Street Technology Select Sector SPDR ETF for 49 Days on average.
| TECH | XLK | |
|---|---|---|
Market Cap | $11.37B | $132.74B |
Volume | 3,153,511 | 6,308,714 |
Sector | Health | Sector/Thematic |
52-Week High | $72.61 | $202.00 |
52-Week Low | $43.31 | $127.49 |
Typical Hold Time | 63 Days | 49 Days |
Enterprise Value | $11.40B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
XLK trades at $201.39, down 0.3% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF faces concentration concerns in semiconductor holdings despite its tech sector diversification. Recent news highlights AI investment opportunities and potential impacts from Federal Reserve policy decisions.
The ETF's outlook remains tied to AI sector performance and interest rate sensitivity. Key opportunities include exposure to software monetization trends, while risks center on semiconductor concentration and potential rate hike impacts. Technical levels show support at $199-200 and resistance at $202-204.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
